Details of the Drug

General Information of Drug (ID: DMVH0SG)

Drug Name
TV1-Kidney-1
Indication
Disease Entry ICD 11 Status REF
Renal cell carcinoma 2C90 Phase 2 [1]
Cross-matching ID
TTD ID
D00HMZ

References

1 Rethinking Immunotherapy for Brain Tumors. Michael D. Becker, MDB Communications LLC. February 22, 2012.